Your browser doesn't support javascript.
loading
Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021.
Miller, Maureen J; Himschoot, Austin; Fitch, Natalie; Jawalkar, Sucheta; Freeman, Dane; Hilton, Charity; Berney, Kevin; Guy, Gery P; Benoit, Tina J; Clarke, Kristie E N; Busch, Michael P; Opsomer, Jean D; Stramer, Susan L; Hall, Aron J; Gundlapalli, Adi V; MacNeil, Adam; McCord, Russell; Sunshine, Gregory; Howard-Williams, Mara; Dunphy, Christopher; Jones, Jefferson M.
Afiliación
  • Miller MJ; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Himschoot A; Georgia Tech Research Institute, Atlanta, Georgia, USA.
  • Fitch N; Georgia Tech Research Institute, Atlanta, Georgia, USA.
  • Jawalkar S; Georgia Tech Research Institute, Atlanta, Georgia, USA.
  • Freeman D; Georgia Tech Research Institute, Atlanta, Georgia, USA.
  • Hilton C; Georgia Tech Research Institute, Atlanta, Georgia, USA.
  • Berney K; Geospatial Research, Analysis, and Services Program (GRASP), Agency for Toxic Substances and Disease Registry, CDC, Atlanta, Georgia, USA.
  • Guy GP; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Benoit TJ; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Clarke KEN; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Busch MP; Vitalant Research Institute, San Francisco, California, USA.
  • Opsomer JD; Westat, Inc, Rockville, Maryland, USA.
  • Stramer SL; Scientific Affairs, American Red Cross, Gaithersburg, Maryland, USA.
  • Hall AJ; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Gundlapalli AV; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • MacNeil A; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • McCord R; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Sunshine G; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Howard-Williams M; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Dunphy C; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
  • Jones JM; CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Clin Infect Dis ; 75(Suppl 2): S264-S270, 2022 10 03.
Article en En | MEDLINE | ID: mdl-35684974
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos